Graftys Granted Patent for CPC Mixed with Blood

Graftys announced that one of its strategic projects has been granted a U.S. patent to have new osteogenic calcium phosphate cement (CPC) technology combined with autologous whole blood tissue.

Responding to a medical need and to a direct request from orthopedic surgeons, a
new generation of macroporous CPC allows surgeons to target new emerging...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us